|1.||Bousson, Valérie: 1 article (09/2013)|
|2.||Parlier-Cuau, Caroline: 1 article (09/2013)|
|3.||Genah, Idan: 1 article (09/2013)|
|4.||Laredo, Jean-Denis: 1 article (09/2013)|
|5.||Touraine, Sébastien: 1 article (09/2013)|
|6.||Petrover, David: 1 article (09/2013)|
|7.||Lagadec, Matthieu: 1 article (09/2013)|
|8.||Roos, Caroline: 1 article (10/2011)|
|9.||Chagnon, Miguel: 1 article (10/2011)|
|10.||Ducros, Anne: 1 article (10/2011)|
|1.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/01/2005 - "Cortivazol has potent antileukemic activity in childhood ALL. "
05/01/2005 - "Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia."
05/01/2005 - "Analysis of ex vivo sensitivity to cortivazol and other glucocorticoids in childhood acute lymphoblastic leukemia, as well as the relationship to anticancer therapy outcome. "
04/15/1989 - "Cortivazol binds to the glucocorticoid receptor in the cytosol from CEM C7 cells (a human acute lymphoblastic leukemia line) in a fashion consistent with interaction with at least two sites. "
10/01/1995 - "Successful in vitro purging of leukemic blasts from marrow by cortivazol, a pyrazolosteroid: a preclinical study for autologous transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma."
|2.||Non-Hodgkin Lymphoma (Lymphosarcoma)
|3.||Myeloid Leukemia (Leukemia, Myelocytic)
03/01/1999 - "Cortivazol provided short-term relief of pain (up to week 4). "
09/01/2004 - "One hundred and twenty-nine joints in 81 RA patients [stratified into 2 groups: wrists (group 1, n = 78) and all the other joints (group 2, n = 51, including 18 elbows, 21 shoulders and 12 ankles)] were randomized to receive intra-articular injections of either 186Re-sulfide (64 +/- 4 MBq), or cortivazol (Altim) 3.75 mg. Clinical assessment was performed before and then at 3, 6, 12, 18 and 24 months after local therapy, using a 4-step verbal rating scale (VRS) and a 100 mm visual analog scale for pain, a 4-step VRS for joint swelling and mobility and a 2-step VRS for the radiological stage. "
01/01/2000 - "Thirty patients with refractory nerve root pain (sciatica, n = 29; femoral neuralgia, n = 1) for a mean of four months were randomized to nerve root injection (n = 17) or interspinous injection (n = 13) of the same mixture of 0.10 g of lidocaine hydrochloride and 3.75 mg of cortivazol. "
|5.||Glucocorticoid Receptors (Glucocorticoid Receptor)